TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Borregaard ASA ( (GB:0QB7) ) has provided an update.
Borregaard ASA has announced the appointment of Knut-Harald Bakke as the new Executive Vice President of BioSolutions, effective August 1, 2025. Bakke, who currently serves as Director of Investor Relations, will also join the Group Executive Management. This leadership change is part of a broader transition as Tom Erik Foss-Jacobsen steps into the CEO role. The company will begin searching for a new Director of Investor Relations, with CFO Per Bjarne Lyngstad temporarily assuming the role. These changes are expected to impact Borregaard’s strategic direction and operational focus in the bio-based solutions sector.
The most recent analyst rating on (GB:0QB7) stock is a Buy with a NOK210.00 price target. To see the full list of analyst forecasts on Borregaard ASA stock, see the GB:0QB7 Stock Forecast page.
More about Borregaard ASA
Borregaard ASA operates in the bio-based solutions industry, focusing on the development and production of sustainable biochemicals and biomaterials. The company is known for its innovative approach to utilizing natural raw materials to create products that serve various markets, including agriculture, construction, and pharmaceuticals.
Average Trading Volume: 81,732
Current Market Cap: NOK19B
For an in-depth examination of 0QB7 stock, go to TipRanks’ Overview page.